97009 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Relaxins
RELAXIN ANALOGS AND METHODS OF USING THE SAME
#2PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#3RELAXIN-2 FUSION PROTEIN ANALOGS AND METHODS OF USING SAME
#4FUSION PROTEIN OF RELAXIN OR ANALOGUE AND MEDICAL USE THEREOF
#5HETERODIMERIC RELAXIN FUSIONS AND USES THEREOF
#6mRNA TREATMENT TO INDUCE EXPRESSION OF RELAXIN FOR REPRODUCTIVE APPLICATIONS
#7Relaxin-2 fusion proteins
#8COMBINATION OF RELAXIN AND VASOPRESSIN ANALOGUES FOR TREATMENT OF RENAL DISORDERS OR CONDITIONS
#9MODIFIED LIPIDATED RELAXIN B CHAIN PEPTIDES AND THEIR THERAPEUTIC USE
#10Modified Relaxin Polypeptides and Their Uses
#11Heterodimeric Relaxin fusions and uses thereof
#12COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF
#13RELAXIN-2 FUSION PROTEIN ANALOGS AND METHODS OF USING SAME
#14PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#15ENGINEERED RELAXINS AND METHODS OF USE THEREOF
#16Modified Relaxin Polypeptides and Their Uses
#17Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides
#18RELAXIN ANALOGS AND METHODS OF USING THE SAME
#19Modified relaxin polypeptides and their uses
#20Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides
#21ADDITIVE SYSTEMS FOR USE IN PROTEIN PEGYLATION
#22Relaxin fusion polypeptides and uses thereof
#23Relaxin immunoglobulin fusion proteins and methods of use
#24Heterodimeric Relaxin fusions polypeptides
#25PRODUCTION OF SOLUBLE RELAXIN AND RELAXIN ANALOGS
#26Modified lipidated relaxin B chain peptides and their therapeutic use
#27Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof
#28PEPTIDES DERIVED FROM PRORELAXIN H1 (RLN1)
#29IN-SILICO METHOD FOR DESIGNING A (D)-POLYPEPTIDE LIGAND
#30Nucleic acids encoding modified relaxin polypeptides
#31Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptides
#32Polynucleotides encoding relaxin
#33Additive systems for use in protein PEGylation
#34Coiled coil immunoglobulin fusion proteins and compositions thereof
#35PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#36Relaxin fusion polypeptides and uses thereof
#37Additive systems for use in protein PEGylation
#38Relaxin immunoglobulin fusion proteins and methods of use
#39Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides
#40Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acid
#41Modified relaxin B chain peptides and their therapeutic use
#42Modified lipidated Relaxin B chain peptides and their therapeutic use
#43Modified lipidated Relaxin B chain peptides and their therapeutic use
#44Method for increasing cardiac inflow by administering a compound that binds RXFP1
#45Peptides and combination of peptides for use in immunotherapy against cancers
#46Polynucleotides encoding relaxin
#47Therapy for Lower Urinary Tract Dysfunctions
#48PEPTIDES DERIVED FROM PRORELAXIN H1 (RLN1)
#49Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chain
#50Methods and compositions related to functional polypeptides embedded in heterologous protein scaffolds
#51Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
#52Peptides and combination of peptides for use in immunotherapy against cancers
#53Therapeutic uses of modified relaxin polypeptides
#54Method for treating heart failure with preserved ejection fraction by administering human relaxin-2
#55Modified relaxin B chain peptides
#56Method of treating heart failure with modified relaxin polypeptides
#57HUMAN RELAXIN ANALOGUE, PHARMACEUTICAL COMPOSITION OF SAME, AND PHARMACEUTICAL APPLICATION OF SAME
#58Coiled coil immunoglobulin fusion proteins and compositions thereof
#59RELAXIN-LIKE COMPOUNDS AND USES THEREOF
#60RELAXIN-LIKE PEPTIDES AND USES THEREOF
#61Bovine fusion antibodies
#62FUSION POLYPEPTIDES AND USES THEREOF
#63Method of lowering mortality
#64Process for preparing human relaxin-2
#65Bovine fusion antibodies
#66Nucleic acids encoding modified relaxin polypeptides
#67Relaxin fusion polypeptides and uses thereof
#68FUSION PROTEINS RELEASING RELAXIN AND USES THEREOF
#69Single chain relaxin polypeptides
#70Method of inducing labor or treating pre-eclampsia by administering relaxin analogs
#71Therapeutic uses of modified relaxin polypeptides
#72Method of lowering mortality
#73Method of treating neurohormonal imbalance
#74Methods of modulating apoptosis by administration of relaxin agonists or antagonists
#75Relaxin polypeptides comprising non-naturally encoded amino acids
#76Method of treating dyspnea associated with acute heart failure by administering H2 relaxin
#77Method of treating dyspnea associated with acute heart failure
#78STRUCTURALLY-RELATED RELAXIN-FUSION PROTEINS WITH EXTENDED IN VIVO HALF-LIVES
#79INTERMEDIATES FORMED IN BIOSYNTHESIS OF RELAXIN-FUSION PROTEINS WITH EXTENDED IN VIVO HALF-LIVES
#80TREATMENT USING RELAXIN-FUSION PROTEINS WITH EXTENDED IN VIVO HALF-LIVES
#81RELAXIN-FUSION PROTEINS WITH EXTENDED IN VIVO HALF-LIVES
#82METHOD OF TREATING CHRONIC HEART FAILURE
#83Relaxin analogs
#84Chimeric relaxin polypeptides comprising an A and B chain derived from different relaxin family peptides
#85Methods of modulating apoptosis by administration of relaxin agonists or antagonists
#86Peptide synthesis
#87HUMAN 3 RELAXIN
#88Modified H2 relaxin for tumor suppression
#89Chimeric peptide antagonist for GPCR135 or GPCR142
#90PROCESS FOR PREPARING THERAPEUTIC PEPTIDE
#91Method of treating dyspnea associated with acute heart failure
#92Peptide having antianxiety activity and screening method therefor
#93HUMAN 3 RELAXIN
#94Method for treatment of anxiety
#95Methods of modulating apoptosis by administration of relaxin agonists or antagonists
#96Relaxin-3 chimeric polypeptides and their preparation and use
#97Relaxin superfamily peptide analogues
#98Relaxin3-gpcr135 complexes and their production and use
#99Methods of using testis-specific insulin homolog polypeptides
#100Antibodies to insulin/IGF/relaxin family polypeptides
#101Relaxin3-GPCR135 complexes and their production and use
#102Complexes of GPCR142 and relaxin3 or INSL5, and their production and use
#103Methods of modulating apoptosis by administration of relaxin agonists or antagonists
#104Human 3 relaxin